Skip to main content
Fig. 10 | BMC Cancer

Fig. 10

From: Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma

Fig. 10

Assessment of Differential Expression of LncRNAs Used for Modelling. Comparison of the differential expression of AL031985.3 (A) and MKLN1-AS (B) between tumour and normal samples from the TCGA-LIHC project. Paired comparison of the differential expression of AL031985.3 (C) and MKLN1-AS (D) between tumour and normal samples from TCGA-LIHC project. Unpaired comparison of the differential expression of AL031985.3 (E) and MKLN1-AS (F) between 32 HCC tissues and 20 adjacent tissues. Paired comparison of the differential expression of AL031985.3 (G) and MKLN1-AS (H) between 20 HCC tissues and 20 adjacent tissues

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us